Articular manifestations in inflammatory bowel disease patients: A prospective study

Digestive and Liver Disease

Volumn 41, Issue 8, 2009, Pages 565-569

  D'Inca R ^a   Podswiadek, M ^a   Ferronato, A ^a   Punzi, L ^a   Salvagnini, M ^b   Sturniolo, G C ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Hospital of Vicenza   (Italy)

Author keywords

Arthropathy; Crohn's disease; Ulcerative colitis

Indexed keywords

ANALGESIC AGENT; AZATHIOPRINE; HLA ANTIGEN; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID; TECHNETIUM 99M;

ADULT; ARTHRALGIA; ARTHRITIS; ARTHROPATHY; ARTICLE; BONE SCINTISCANNING; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTERVIEW; LOCOMOTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOLOGY; SELF REPORT; ULCERATIVE COLITIS;

ADULT; ARTHRALGIA; ARTHRITIS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HLA-B27 ANTIGEN; HUMANS; INTESTINES; MALE; SPONDYLITIS, ANKYLOSING;

EID: 67649663956     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.01.013     Document Type: Article

References (29)

1. Greenstein A., Janowitz H., and Sachar D. Extraintestinal complications of Crohn's disease and ulcerative colitis. Medicine 55 (1976) 401-412
2. Tavarela Veloso F., Carvalho J., and Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 23 (1996) 29-34
3. Bernstein C.N., Blanchard J.F., Rawsthorne P., and Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96 (2001) 1116-1122
4. Brophy S., Pavy S., Lewis P., Taylor G., Bradbury L., Robertson D., et al. Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors. J Rheumatol 28 (2001) 2667-2673
5. Gran J.T., and Husby G. Joint manifestations in gastrointestinal diseases. Dig Dis 10 (1992) 274-294
6. Mielants H., Veys E.M., Cuvelier C., and de Vos M. Course of gut inflammation in spondyloarthropathies and therapeutic consequences. Bailliere's Clin Rheumatol 10 1 (1996) 147-164
7. Aho K. Bowel infection predisposing to reactive arthritis. Bailliere's Clin Rheumatol 3 (1989) 303-319
8. Palm O., Moum B., Jahnsen J., and Gran J.T. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology 40 (2001) 1256-1261
9. Suh C.H., Lee C.H., Lee J., Song C.H., Lee C.W., Kim W.H., et al. Arthritic manifestations of inflammatory bowel disease. J Korean Med Sci 13 (1998) 39-43
10. MacRae I.F., and Wright V. Measurement of back movement. Ann Rheum Dis 28 (1969) 584-589
11. Dougados M., Van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., et al. The European Spondyloarthropathy study group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34 (1991) 1218-1227
12. Van der Linden S., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27 (1984) 361-368
13. Orchard T.R., Wordsworth B.P., and Jewell D.P. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42 (1998) 387-391
14. Forrest E.H., and Russell R.I. Peripheral arthropathies in inflammatory bowel disease. Gut 44 (1999) 439-442
15. Weiner S.R., Clarke J., Taggart N.A., and Utsinger P.D. Rheumatic manifestations of inflammatory bowel disease. Semin Arth Rheum 20 (1991) 353-366
16. McErlane F., Gillon C., Irvine T., Davidson J.E., Casson D., Dalzell A.M., et al. Arthropathy in paediatric inflammatory bowel disease: a cross-sectional observational study. Rheumatology 47 (2008) 1251-1252
17. Steer S., Jones H., Hibbert J., Kondeatis E., Vaughan R., Sanderson J., et al. Low back pain, sacroiliitis, and the relationship with HLA-B 27 in Crohn's disease. J Rheumatol 30 (2003) 518-522
18. Hyla J.F., Franck W.A., and Davis J.S. Lack of association of HLA-B27 with radiographic sacroiliitis in inflammatory bowel disease. J Rheumatol 3 (1976) 196-200
19. Enlow R.W., Bias W.B., and Arnett F.C. The spondylitis of inflammatory bowel disease. Evidence for a non-HLA linked axial arthropathy. Arthritis Rheum 23 (1980) 1359-1365
20. Huerta-Sil G., Casasola-Vargas J.C., Londono J.D., Rivas-Ruiz R., Chavez J., Pacheco-Tena C., et al. Low-grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling ankylosing spondylitis diagnostic criteria throughout follow up. Ann Rheum Dis 65 (2006) 642-646
21. de Vlam K., Mielants H., Cuvelier C., DeKeyser F., Veys E.M., and DeVos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 27 (2000) 2860-2865
22. Rhodes J.M., and Collins P. Lessons for inflammatory bowel disease from rheumatology. Dig Liv Dis 38 (2006) 157-162
23. Orchard T.R., Thiygaraya S., Welsh K., Wordsworth P.B., Hill Gaston J.S., and Jewell D.P. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 118 (2000) 274-278
24. Purrmann J., Zeidler H., Pertrams J., Juli E., Cleveland S., Berges W., et al. HLA antigens in ankylosing spondylitis associated with Crohn's disease. Increased frequency of the HLA phenotype B27, and B44. J Rheumatol 15 (1988) 1658-1661
25. Porzio V., Biasi G., Corrado A., De Santi M., Vindigni C., Viti S., et al. Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis. Scand J Rheumatol 26 (1997) 92-98
26. Punzi L., Podswiadek M., D'Incà R., Zaninotto M., Bernardi D., Plebani M., et al. Serum human cartilage glycoprotein 39 as a marker of arthritis associated with inflammatory bowel disease. Ann Rheum Dis 62 (2003) 1224-1226
27. Reinisch W., Miehsler W., Dejaco C., Harer M., Waldhoer T., Lichtenberger C., et al. An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia. Aliment Pharmacol Ther 17 (2003) 1371-1380
28. Farmer R.G., Hawk W.A., and Turnbull Jr. R.B. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 68 (1975) 627-635
29. Felder J.B., Korelitz B.I., Rajapakse R., Schwarz S., Horatagis A.P., and Gleim G. Effects of nonsteroidal anti-inflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol 95 (2000) 1949-1954